Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean - Forge Biologics

Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean

COLUMBUS, OHIO April 6, 2021 – Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller, Ph.D., Chief Executive Officer, President, and Co-Founder will present at the annual Cell & Gene Meeting on the Mediterranean, which will be held virtually April 6-9, 2021.

Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mediterranean is a four-day virtual conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies.

“I’m honored to be presenting alongside a lineup of industry leaders and to share the  groundbreaking progress that Forge Biologics has made in less than 9 months since closing our Series A in July 2020,” said Dr. Miller.

Forge Biologics’ company presentation will be available to view on-demand throughout the entirety of the conference. Attend the conference at

About Forge Biologics

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutic development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea into reality. Forge has a 175,000 ft2 facility in Columbus, Ohio, “The Hearth,” to serve as their headquarters. The Hearth is the home of a custom-designed cGMP facility dedicated to AAV viral vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most.

For more information, please visit

Media Inquiries:
Dan Salvo
Director of Communications and Community Development
Forge Biologics Inc.

Business Development:
Magdalena Tyrpien
Vice President and Head of Business Development
Forge Biologics Inc.

Investor Relations
Christina Perry
Vice President, Finance and Operations
Forge Biologics Inc.

Patient, Pediatrician, Genetic Counselors & Family Inquiries
Dr. Maria Escolar
Chief Medical Officer
Forge Biologics Inc.

0/5 (0 Reviews)